Learn how chemotherapy agents can trigger peripheral neuropathy, leading to a range of neuromuscular issues stemming from damage to peripheral nerve fibers in this RACGP CPD course.
This is a RACGP CPD module with an allocated 1 hour of Education Activities (EA), 5 hours of Measuring Outcomes (MO), and 1 hour of Reflective Practice (RP) under the RACGP 2023-25 CPD program.
Learning Objectives:
- Discuss the incidence and prevalence of Chemotherapy Induced Peripheral Neuropathy (CIPN)
- Discuss patients at greatest risk of CIPN
- Discuss the identification and management of CIPN in the GP setting
This activity is presented by Dr Andrea Tazbirkova, a Medical Oncologist at the Gold Coast Private Hospital. Dr Tazbirkova has special interests in urogenital, colorectal and lung malignancies as well as a particular interest in breast and gynaecological cancers. Click here to connect with Dr Tazbirkova.
*If you’d like to watch this presentation alone without doing the CPD Activity, click here.
